Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis

Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis

Angong Niuhuang Pill (ANP) is a well-known patented Chinese medicine which is used for hundreds of years for treating the central nervous system diseases. Atherosclerosis is a poly-aetiological chronic inflammatory vascular disease. Preventing inflammation is fundamental for treating atherosclerosis...

Full description

Bibliographic Details
Main Authors: Qinghong Fan, Yujuan Liu, Jiaoyu Rao, Zhe Zhang, Wei Xiao, Tao Zhu, Xiaomeng Chai, Kaihe Ye, Na Ning, Zhen Yin, Yushuang Chai, Yimin Xu, Ruirui Lan, A Verkhratsky, Hong Nie
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Pharmacology
Subjects:
Angong Niuhuang Pill
early and mid-term atherosclerosis
ApoE-/- mice
Th17/Treg balance
inflammation
plaque stability
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01584/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01584/full

Similar Items